|
CUL4B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13329999829048E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.34319946463324E-10 |
| Normal-vs-Stage2 |
1.550030E-02 |
| Normal-vs-Stage3 |
1.416140E-03 |
| Normal-vs-Stage4 |
2.728200E-02 |
| Stage1-vs-Stage2 |
3.080400E-01 |
| Stage1-vs-Stage3 |
1.101840E-01 |
| Stage1-vs-Stage4 |
5.615000E-01 |
| Stage2-vs-Stage3 |
8.805800E-01 |
| Stage2-vs-Stage4 |
8.816600E-01 |
| Stage3-vs-Stage4 |
7.677200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.32370003846916E-09 |
| Normal-vs-AfricanAmerican |
8.234800E-01 |
| Normal-vs-Asian |
2.605400E-01 |
| Caucasian-vs-AfricanAmerican |
2.37449999999084E-05 |
| Caucasian-vs-Asian |
7.998000E-01 |
| AfricanAmerican-vs-Asian |
1.804610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.92270000318484E-08 |
| Normal-vs-Female |
2.0256999999968E-05 |
| Male-vs-Female |
3.998800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.340800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.16069999944735E-07 |
| Normal-vs-Age(61-80Yrs) |
5.56499999970761E-07 |
| Normal-vs-Age(81-100Yrs) |
7.767200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.813900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.614400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.704600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.370800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.219300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.797600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.600800E-03 |
| Normal-vs-Grade 2 |
1.75269798674549E-11 |
| Normal-vs-Grade 3 |
1.826250E-04 |
| Normal-vs-Grade 4 |
2.934600E-01 |
| Grade 1-vs-Grade 2 |
5.425800E-01 |
| Grade 1-vs-Grade 3 |
4.105900E-02 |
| Grade 1-vs-Grade 4 |
4.743700E-02 |
| Grade 2-vs-Grade 3 |
6.224200E-04 |
| Grade 2-vs-Grade 4 |
3.458100E-02 |
| Grade 3-vs-Grade 4 |
5.590600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.31716901011714E-14 |
| Normal-vs-ccB subtype |
2.662700E-03 |
| ccA subtype-vs-ccB subtype |
1.62592999999323E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.9497000000035E-06 |
| Normal-vs-N1 |
7.129800E-01 |
| N0-vs-N1 |
7.541600E-02 |
|
|
